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Elizabeth T. Snow
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Chromium is an environmentally significant human carcinogen with complicated metabolism and an unknown mechanism of mutagenesis.
Chromium(VI) is taken up by cells as the chromate anion and is reduced intracellularly via reactive intermediates to stable Cr(III) species.
Chromium(lll) forms tight complexes with biological ligands, such as DNA and proteins, which are slow to exchange. In vitro, CrCI3.6H2O primarily
interacts with DNA to form outer shell charge complexes with the DNA phosphates. However, at micromolar concentrations, the Cr(1II) binds to a
low number of saturable tight binding sites on single-stranded M13 DNA. Additional chromium interacts in a nonspecific manner with the DNA and
can form intermolecular DNA cross-links. Although high concentrations of Cr(1II) inhibit DNA replication, micromolar concentrations of Cr(Ill) can sub-
stitute for Mg2+, weakly activate the Klenow fragment of E. coli DNA polymerase (Pol l-KF), and act as an enhancer of nucleotide incorporation.
Alterations in enzyme kinetics induced by Cr(111) increase DNA polymerase processivity and the rate of polymerase bypass of DNA lesions. This
results in an increased rate of spontaneous mutagenesis during DNA replication both in vitro and in vivo. Our results indicate that chromium(llI) may
contribute to chromate-induced mutagenesis and may be a factor in the initiation of chromium carcinogenesis. - Environ Health Perspect
102(Suppl 3:41-44 (1994).
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Introduction
Metal compounds, as a class, are among
the best documented ofall human carcino-
gens (1), but the mechanisms of metal car-
cinogenesis are not fully understood.
Although it is often assumed that carcino-
genesis is (at least in part) the result of
DNA damage and mutagenesis, metals
have many genotoxic effects and the rela-
tive importance ofthese different effects are
not known. Each metal-and in many
cases different compounds of a single
metal-exhibits a unique spectrum of
genotoxic effects. Cr(VI) or chromate, the
biologically active form of environmental
chromium, is taken up by cells and reduced
intracellularly to reactive Cr(V) and Cr(IV)
species and then to stable Cr(III). In the
process, chromium induces oxidative DNA
damage, DNA strand breaks, DNA-DNA
and DNA-protein cross-links, and muta-
tions (2-4). The genetic consequences of
the different types ofchromium complexes
and the relative importance of oxidative
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DNA damage are unknown. Although
much of the published research on the
mechanisms of chromium-induced geno-
toxicity has dealt with the complex intra-
cellular metabolism of chromium and the
DNA damage produced by Cr(VI) in
whole cells (5,6), it is well established that
only the reduced forms ofchromium, such
as Cr(V) and Cr(III), form complexes with
DNA and proteins (6,7). Cr(III), for
example, forms stable complexes with lig-
ands on DNA, proteins, and small mole-
cules such as glutathione. Since these
complexes constitute the most persistent
form of intracellular chromium their
impact on chromium toxicology is of sig-
nificance. The research outlined here
describes the effects of Cr(III)-DNA com-
plexes on DNA replication in vitro.
Materials and Methods
Ml3mp2 single-stranded DNA was pre-
pared as previously reported (8) using
standard procedures (9). Unlabeled deoxy-
nucleotides were obtained from Sigma
Chemical Company (St. Louis, MO). 32p
labeled deoxynucleoside triphosphates were
from New England Nuclear (Boston, MA)
and the M13 sequencing primers were
either purchased from New England
BioLabs (Beverly, MA) or synthesized by
Dr. Bernard Goldschmidt, Department of
Environmental Medicine, NYU Medical
Center. Polymerase I-Klenow fragment was
obtained from Pharmacia, Inc., Piscataway,
NJ, and polynucleotide kinase was from
New England BioLabs (Beverly, MA). All
other reagents and chemicals were ofmole-
cular biology or DNA grade. Chromium
solutions were made daily and all water was
purified through a Milli-Q water system
from Millipore.
Single-stranded M13mp2 DNA and
Cr(Ill)-treated DNA was prepared and
hybridized with a 2-fold excess of 17-mer
primer ("-40 primers," New England
BioLabs) as described previously (8). For
measurement of nucleotide incorporation,
the untreated and chromium-treated M13
DNA was primed and replicated in vitro
using oX P-labeled dATP as a label and
0.02 to 0.2 units of DNA polymerase I-
Klenow fragment (Pol I-KF). The reaction
was stopped by the addition of disodium
ethylenediamine tetraacetate (EDTA) and
10% trichloroacetic acid (TCA) (8).
Mutagenesis assays were performed as
described previously (8) using an E. coli
strain (NR9064) in which the mutS gene
was inactivated by TN10 transduction giv-
ing a mismatch repair-deficient phenotype
(10). SOS induction was achieved as
described previously (11) by irradiating the
cells with a dose of75 J/M2 UVC prior to
CaCl2 treatment.
Preparation ofss Linear DNA
FragmentbyAsymmetric PCR
For analysis of bypass of oxidative DNA
lesions, an asymmetric polymerase chain
reaction (PCR) protocol was used to gener-
ate a 167-nucleotide DNA fragment from
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M13mp2 DNA. Each 100 pl PCR reaction
mixture contained 50 mM KCl, 10 mM
Tris-HCl pH 8.3, 1.5 mM MgCI2, 50 pM
each dATP, dCTP, dGTP, dTTP, 0.01%
gelatin, 100 pmole M13 17-mer reverse
primer, 1 pmole 15-mer (aa 46-50, corre-
sponding to the minus-strand sequence at
amino acids 46-50 in the lacZgene), 20 ng
M13mp2 double-stranded DNA template
and 2.5 units Taq polymerase (Perkin
Elmer). The PCR reactions were continued
for 30 cycles to optimize the amplification.
The amplified fragments were identified by
agarose gel electrophoresis and by
hybridization of a radioactive labeled 15-
base oligonucleotide probe prepared by
[a32P]ATP end-labeling of the aa46-50
primer.
Oxidative DamageofssDNAFragment
with KMnO4
An oxidatively modified DNA template
was prepared by incubating 5 pg ofthe sin-
gle-stranded PCR products prepared as
described above with 500 pM KMnO4 in a
25 pl final volume in the presence of 50
mM Tris-HCI, pH7.4, for 30 min at 37C.
The oxidized DNA was purified by
Sephadex G-50 spin columns and then
treated with CrCI3.6H20 and hybridized
with 5'-end labeled 15-mer primers (46-50
aa) as described above. The bypass of
oxidative lesions (primarily thymine gly-
cols) by Klenow fragment (0.01 units/reac-
tion) was measured by primer-extension at
37°C for 5 min under the same conditions
as for nucleotide incorporation. The
extended primers were examined by 8%
polyacrylamide sequencing gel elec-
trophoresis. The dried gels were autoradi-
ographed and the films were scanned by
densitometer to quantify the bypass of
lesions.
Results and Discussion
Cr(III) CanAcdvate DNAReplicaton
bypol I-KF on aPrimedSinle-
Stranded DNATemplate
It is generally recognized that the Mg2+
cation is the primary metal cofactor for
DNA polymerase activity. It was, there-
fore, a surprise to find, in two separate
experiments, that Cr3+ can also allow
DNA replication in vitro by pol I-KF in
the absence of Mg2+ (manuscript in
preparation). At an optimum concentra-
tion of 5 pM, CrCl3 catalyzed the incor-
poration of an average of 1.09 ± 0.58
pmole dAMP per min (± standard devia-
tion) on a primed single- stranded
M1r3mp2 template. This is equivalent to
iable 1. Reversion mutagenesis of chromium-treated Ml3mp2-C141 phage DNA transfected into mismatch repair-
deficient NR9064 (mutS) E colihost cells.
Survival Mutant
CrCl3 (pM) Total plaques %control No. mutants Frequency (x10-4)
Expt. 1 (SOS-)
0 65,125 100 10 1.3±0.3
5 24,498 38±1 10 4.0±0.2
10 1,712 7±8 16 94±25
Expt. 2 (Stored)
0 22,304 100 0 <0.5
5 22,529 101 0 <0.4
10 39,218 54 0 <0.3
Expt. 3 (SOS+)
0 43,066 100 6 0.9± 0.1
5 15,040 25±7 3 2.0±1.0
10 11,784 2±1 1 0.8
Expt. 1 = Freshly treated DNAtransfected into non-SOS induced host cells. Expt. 2 = Pretreated DNA which was stored
for 23 days before transfection into non-SOS induced host cells. Expt. 3 = Freshly treated DNA transfected into SOS
induced hostcells.
23% of the rate of Mg2+-catalyzed
nucleotide incorporation measured in the
same set of experiments. The mechanism
of interaction between Cr(III) and the
polymerase is not known. However, it is
possible that the Cr(III) forms a biden-
tate-P,By-complex (12) with the dNTP at
the dNTP binding site on the poly-
merase. This Cr(III)-complex may then
facilitate the pyrophosphatase reaction by
providing a better leaving group than a
Mg-P,y-complex. This hypothesis is sup-
ported by kinetic analysis of nucleotide
incorporation by pol I-KF in the presence
ofCr(III) which shows that 5 pM Cr(III)
increases the Vma: by 160% and increases
the apparent KM for dATP by a factor of
10 (13). At higher concentrations (10 pM
and above), Cr(III) inhibits both the ini-
tiation and extension of replication by
DNA polymerases.
Cr(III) Interactswith the DNA
Template andIncreases DNA
Polymerase Processivityandthe Rate
ofNudeotide Incorporation
We have found that Cr(III) interacts with
single-stranded M13 DNA in vitro in a
biphasic manner (8). Scatchard analysis of
the binding from 0 to 5 pM Cr(MII) shows
that the metal ions bind to approximately
120 tight binding sites per DNA molecule
with a dissociation constant of approxi-
mately 4 pM (Snow et al., unpublished).
Higher concentrations ofCr(III) bind non-
specifically to the DNA. The chromium
bound to the DNA either interacts with
DNA polymerases or acts as a source of
very low concentrations offree Cr(III) dur-
ing replication. This low concentration of
Cr(III) increases DNA polymerase proces-
sivity and decreases DNA replication
fidelity (14).
- xdal (KMnOOMDw.g
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Figure 1. Autoradiograph of primer extension on a 167-nucleotide single-stranded KMnO4-treated DNAtemplate in the
presence of increasing concentrations of Cr(lIl). The top panel shows primer extension on a KMnO4-treated template in
the presence of increasing concentrations of Cr(ll). The arrow at the top indicates the end of the template. The bottom
panel shows the sequence of the full length M13 template run on the same gel as shown above. Note that beyond the
initial pause sites typical for primer extension on thistemplate (atthe left side ofthe gel), all polymerase pause sites on
the KMnO4-treated template are found adjacent to or immediately before template thymidine residues (the top lane of
panel 2)and aretherefore indicative ofpausing atoxidizedthymine lesions.
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The Cr(III)-mediated increase in poly-
merase processivity has been demonstrated
by both primer extension analysis (8) and a
newly developed competition assay using
two different sized DNA templates (13).
These assays show that Cr(III) bound to
the DNA decreases the initiation ofreplica-
tion while, at the same time, the number of
nucleotides incorporated per initiated tem-
plate (a measure of processivity) is
increased from 200% to 470% (8,13). The
results suggest that the rate of binding of
the polymerase to the Cr(III)-treated tem-
plate is decreased, but that once bound the
polymerase can incorporate more
nucleotides before dissociating from the
template.
The effects of Cr(III) on DNA poly-
merase processivity are not limited to Pol I-
KF; other DNA polymerases show
increased rates of nucleotide incorporation
and increased processivity in the presence
of Cr(III). We have shown, for example,
that calf thymus polymerase a and cloned
human DNA polymerase m both show
enhanced processivity in the presence of
Cr(III) (14,15). The most dramatic effect
observed during replication of single-
stranded M13mp2 DNA by polymerase a
in the presence ofCrCl3 is the loss of nor-
mal polymerase pause sites (16). Although
polymerase I is not very active on a single
stranded DNA template when Mg2+ is
used as the cofactor; both Mn(II) (17) and
Cr(III) (data not shown) are able to
increase the activity of pol 0 on single-
stranded M13 DNA (14,16). Not all poly-
merases are activated by Cr(III), however.
T4 phage DNA polymerase, a normally
processive enzyme, is inhibited by as little
as 0.5 pM Cr(III) and does not show any
significant activation by this trivalent
cation, even in the absence ofMg (data not
shown).
MutagenicEffets ofCr(IU)
The effect of Cr(III) on the fidelity of
eukaryotic enzymes is unknown; however,
we have shown that the presence ofCr(III)
during replication by E. coli DNA poly-
merases either in vitro or in vivo is muta-
genic. A 2- to 4-fold increase in
mutagenesis by Cr(III) was previously
reported using the lacZa gene ofMl3mp2
as a mutagenic target (8,14,15). More
recently we have found that, if a mutant
M13 phage DNA (Ml3mp2-C141) is
replicated in the presence of Cr(III) in a
mismatch repair deficient E. coli host,
reversion mutagenesis is increased up to
94-fold in non-SOS-induced cells, but not
in SOS-induced cells (Table 1). The
chromium-dependent increase in mutagen-
esis requires the use of freshly treated
DNA. Ifthe chromium is allowed to equi-
librate between the DNA and the buffer by
storing the treated DNA (from which the
unbound Cr(III) was removed by gel filtra-
tion) for 23 days before transfection no
mutagenesis is seen. Some residual damage
or bound chromium in the 10 pM treated
sample does, however, produce a 46%
decrease in phage recovery (Table 1).
In contrast to the strong mutagenic
response seen in mismatch repair-deficient
cells, reversion mutagenesis by Cr(III) only
reaches a maximum of 2- to 3-fold above
background in a mismatch repair-proficient
host (8). This suggests that most of the
errors introduced during replication in the
presence of Cr(III) can be repaired by
either mismatch repair or are mitigated by
SOS-associated processes. This may indi-
cate that the RecA protein, a single-strand
binding protein present at high concentra-
tion in the SOS-induced cells, can displace
the Cr(III) from the DNA and thus miti-
gate the effects ofthe metal ion on replica-
tion. It can also be seen in Table 1 that 10
pM Cr(III) [a concentration which induces
significant amounts of DNA crosslinking
(8)] is significantly more mutagenic than 5
pM Cr(III) under non-SOS conditions,
but not after SOS-induction. This implies
that base substitution mutagenesis by
Cr(III) may be promoted by DNA
crosslinking and that the resulting mis-
matches may be repaired by either the mis-
match repair system or by SOS-dependent
processing.
Several ofthe Cr(III)-induced and spon-
taneous mutants were isolated and
sequenced (Table 2). The results show that
Cr(III) produces a significant increase in
the frequency of C-+A transversion muta-
tions (at C141) relative to the spontaneous
mutant spectrum. DNA replication in the
presence of Cr(III) produced 31% C->A
transversions, 19% C-+G transversions,
and 50% C-*T transitions at target sites
C141 and C142; whereas the spontaneous
mutations at the same sites consisted of9%
C-+A transversions; 27% C-*G transver-
sions, and 64% C->T transitions.
Spontaneous mutagenesis in a mismatch
repair-deficient host has been shown to
consist primarily ofan increased frequency
oftransition mutations (10); therefore, this
increase in transversions induced by Cr(III)
may indicate a significant alteration in the
type of misincorporation that occurs dur-
ing DNA replication in the presence ofthis
metal ion.
Cr(Il) IncreasesPolymerase Bypass of
DNADamage
The evidence for increased polymerase pro-
cessivity, along with increased mutagenesis
in the presence of Cr(III), led us to ask
whether Cr(III) can increase polymerase
bypass of other types of DNA damage.
Since it has been shown that the intracellu-
lar reduction of chromium(VI) produces
oxidative base damage (17,18), we investi-
gated the ability of Cr(III) to promote
bypass of oxidative DNA lesions. A 167-
nucleotide single-stranded fragment of
Ml3mp2 DNA was prepared and oxidized
with KMnO4, producing enough DNA
damage (mostly thymidine glycols) to
almost completely block replication at or
before the first template thymidine (19).
The KMnO4-treated DNA was further
treated with 0 to 25 pM CrCl3 and then
primed with an y32P-labeled primer.
Replication of the treated primer-template
was carried out with 0.01 unit ofPol I-KF
and the products of replication were ana-
lyzed on an 8% polyacrylamide/7 M urea
sequencing gel. In the absence of Cr(III),
replication was limited and barely reached
the first putative thymidine glycol (Figure
1). Fewer than 1% of the primers were
extended beyond the first template
thymine residue. After treatment of the
oxidized DNA with 1 to 5 pM Cr(III),
replication was greatly extended and
increased bypass ofthe oxidized DNA base
Table 2. Sequence specificity ofCr(ll)-induced reversion mutagenesis in Ml3mp2-C141.
Targetbase
Newbase C141 C142
Spontaneous A 1 0
G 3 0
T 4 3
Cr-induced A 5 0
G 3 0
T 1 7
The numberofC-+A, C->G, and C-*T mutations ateach ofthetargetsites is given foratotal of 11 spontaneousand
16 Cr-induced mutants.
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damage was evident (Figure 1) (13). In the
presence of up to 5 pM Cr(III), from 5%
to 29% of the primers were extended
beyond the first thymidine. Higher con-
centrations of Cr(III), in the range of 10
to 25 pM, led to the formation of DNA-
DNA crosslinks (seen at the top ofthe gel,
to the right of the figure) and decreased
polymerase activity. We are currently
investigating the fidelity and kinetics of
nucleotide incorporation opposite the
oxidative lesions to understand the mech-
anism by which Cr(III) mediates the
bypass ofpolymerase blocking lesions.
In summary, micromolar concentra-
tions of Cr(III) bound to the DNA tem-
plate can increase DNA polymerase
processivity and decrease DNA replication
fidelity. These alterations in DNA func-
tion can result in greatly increased bypass
of oxidative DNA lesions. Since several
oxidative base lesions, such as 8-
oxodeoxyguanine have been shown to be
promutagenic (20), Cr(III) may serve to
increase the mutagenic potential of these
lesions and contribute to the genotoxic
effects ofchromium in vivo.
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